Marketing Authorization for its product Exemestane - Marksans Pharma Ltd

Code BSE: 524404 NSE:

Marksans Pharma Limited hereby announces that its wholly owned subsidiary Relonchem Limited in UK has received Marketing Authorization for its product Exemestane 25mg film-coated tablets from UK MHRA.